Company Directory - 60 Degrees Pharmaceuticals, Inc.
Company Details - 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc.
Website60 Degrees Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative therapies to address unmet medical needs, particularly in the field of infectious diseases.
CCI Score
CCI Score: 60 Degrees Pharmaceuticals, Inc.
3.48
Latest Event
Patent License Agreement with Yale
60 Degrees Pharmaceuticals, Inc. announced a patent license agreement with Yale’s School of Medicine and Public Health for the development and commercialization of Tafenoquine, an event that drove a 109% surge in its share price. This agreement highlights a commitment to innovation and ethical business practices in advancing public health.
Take Action
So what can you do? Support 60 Degrees Pharma by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
OBJECTOR
60 Degrees Pharmaceuticals, Inc. is currently rated as an Objector.
Latest Events
- APR082025
60 Degrees Pharmaceuticals, Inc. announced a patent license agreement with Yale’s School of Medicine and Public Health for the development and commercialization of Tafenoquine, an event that drove a 109% surge in its share price. This agreement highlights a commitment to innovation and ethical business practices in advancing public health.
- DEC312017
60 Degrees Pharmaceuticals, Inc. spent $30,000 on lobbying activities in 2017, as reported by OpenSecrets, indicating its corporate engagement in influencing political processes.
-40
Political Contributions and Lobbying Efforts
April 8
The reported lobbying expenditure of $30,000 in 2017 demonstrates an engagement in political lobbying efforts, which can contribute to corporate influence over public policy. From an anti-fascist perspective, such corporate political activity is concerning as it may help perpetuate power structures that undermine democratic accountability and favor authoritarian-aligned policies.
- JAN012017
An OpenSecrets report indicates that 60 Degrees Pharmaceuticals spent $30,000 on lobbying efforts in 2017, reflecting the company's active engagement in political influence activities.
-20
Political Contributions and Lobbying Efforts
April 8
The report details that 60 Degrees Pharmaceuticals allocated $30,000 toward lobbying in 2017. From an anti-authoritarian perspective, corporate lobbying raises concerns about disproportionate influence over political processes and policy decisions, contributing to the erosion of democratic oversight.
- JAN012017
In 2017, 60 Degrees Pharmaceuticals spent $30,000 on lobbying by hiring firms, as tracked by OpenSecrets. This activity indicates the company’s engagement in political influence via lobbying, a practice that can undermine democratic accountability.
-30
Political Contributions and Lobbying Efforts
April 8
The company’s expenditure of $30,000 on lobbying in 2017 demonstrates an active involvement in influencing political processes, which may favor elite interests over broader societal welfare and could contribute to authoritarian policy environments.
Alternatives
Copenhagen, Denmark
2.36
Corporation
0.00
Corporation
-43.74
Kenilworth, United States
2.89
New Haven, USA
-38.83
Corporation
2.31
Corporation
1.66
Corporation
1.00
Belgium (Ghent), Belgium
79.03
Raleigh, USA
56.52
Industries
- 325412
- Pharmaceutical Preparation Manufacturing
- 541712
- Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)
- 541711
- Research and Development in Biotechnology